{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T21:49:31Z","timestamp":1776116971412,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013059","name":"Jiangsu Provincial Medical Youth Talent","doi-asserted-by":"publisher","award":["QNRC2016658"],"award-info":[{"award-number":["QNRC2016658"]}],"id":[{"id":"10.13039\/501100013059","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Preventive Medicine Association Project","award":["Y2018091"],"award-info":[{"award-number":["Y2018091"]}]},{"name":"Jiangsu Cancer Hospital Project","award":["ZQ201107"],"award-info":[{"award-number":["ZQ201107"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To recommend a cranial border for level IIb in delineating clinical target volumes (CTV) for nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy and to help reach a consensus on contouring level IIb in CTV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From 2012 to 2016, 331 nonmetastatic NPC patients treated with IMRT were retrospectively enrolled. Based on the AJCC 8th staging system of NPC, there were 15 stage I, 76 stage II, 103 stage III, and 137 stage IV patients. The distribution of cervical lymph nodes in NPC was assessed based on imaging. Comparisons of the safety and parotid dose parameters between patients with and without a reduction in the size of level IIb were conducted using SPSS 25.0 and R 2.14.2 software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Metastasis rates in the most commonly involved lymph nodes, the lateral retropharyngeal and IIb nodes, were 82.8% and 64.0%, respectively. Among patients with level IIb involvement, the upper borders of the metastatic nodes were beyond the caudal edge of C1 in 13.7% of cases. The parotid gland D50 and V26 values were significantly reduced after modifying the upper bound of level IIb used to delineate the CTV (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.000).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In principle, the upper bound of level IIb should reach the lateral skull base during delineation of the cervical CTV for NPC. To protect the parotid glands, however, individualized reduction of the upper bound of level IIb is recommended for patients who meet certain criteria.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13014-020-01720-2","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T14:04:05Z","timestamp":1606140245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Recommendation regarding the cranial upper border of level IIb in delineating clinical target volumes (CTV) for nasopharyngeal carcinoma"],"prefix":"10.1186","volume":"15","author":[{"given":"Lijun","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3151-8139","authenticated-orcid":false,"given":"Shengfu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yatian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"key":"1720_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J, et al. Nasopharyngeal carcinoma [Incidence and mortality of nasopharyngeal carcinoma in China, 2014] Management of locally recurrent nasopharyngeal carcinoma. Lancet. 2019;394:64\u201380.","journal-title":"Lancet"},{"key":"1720_CR2","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.ijrobp.2017.11.004","volume":"100","author":"L Lin","year":"2018","unstructured":"Lin L, Lu Y, Wang XJ, Chen H, Yu S, Tian J, et al. Delineation of neck clinical target volume specific to nasopharyngeal carcinoma based on lymph node distribution and the international consensus guidelines. Int J Radiat Oncol Biol Phys. 2018;100:891\u2013902.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1720_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.radonc.2017.10.032","volume":"126","author":"AW Lee","year":"2018","unstructured":"Lee AW, Ng WT, Pan JJ, Poh SS, Ahn YC, AlHussain H, et al. International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiother Oncol. 2018;126:25\u201336.","journal-title":"Radiother Oncol"},{"key":"1720_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.radonc.2003.09.011","volume":"69","author":"V Gregoire","year":"2003","unstructured":"Gregoire V, Levendag P, Ang KK, Bernier J, Braaksma M, Budach V, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol. 2003;69:227\u201336.","journal-title":"Radiother Oncol"},{"key":"1720_CR5","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.radonc.2013.10.010","volume":"110","author":"V Gr\u00e9goire","year":"2014","unstructured":"Gr\u00e9goire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA, et al. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol. 2014;110:172\u201381.","journal-title":"Radiother Oncol"},{"key":"1720_CR6","first-page":"176","volume":"19","author":"VF Chong","year":"2010","unstructured":"Chong VF, Fan YF, Khoo JB. Retropharyngeal lymphadenopathy in nasopharyngeal carcinoma. Head Neak. 2010;19:176\u201381.","journal-title":"Head Neak"},{"key":"1720_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/(SICI)1097-0347(200005)22:3<275::AID-HED10>3.0.CO;2-N","volume":"22","author":"AD King","year":"2000","unstructured":"King AD, Ahuja AT, Leung SF, Lam WW, Teo P, Chan YL, et al. Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head Neck. 2000;22:275.","journal-title":"Head Neck"},{"key":"1720_CR8","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1148\/radiol.2303030157","volume":"230","author":"AD King","year":"2004","unstructured":"King AD, Tse GMK, Ahuja AT, Yuen EHY, Vlantis AC, To EWH, et al. Necrosis in metastatic neck nodes: diagnostic accuracy of CT, MR imaging, and US. Radiology. 2004;230:720\u20136.","journal-title":"Radiology"},{"key":"1720_CR9","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00259-004-1498-9","volume":"31","author":"SH Ng","year":"2004","unstructured":"Ng SH, Chang JT-C, Chan S-C, Ko S-F, Wang H-M, Liao C-T, et al. Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. Eur J Nucl Med Mol Imaging. 2004;31:1073\u201380.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"177","key":"1720_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1148\/radiology.177.2.2217772","volume":"1990","author":"MWMJR Van Den Brekel","year":"1990","unstructured":"Van Den Brekel MWMJR. Cervical lymph node metastasis: assessment of radiologic criteria. Radio. 1990;1990(177):379\u201384.","journal-title":"Radio"},{"key":"1720_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0167-8140(95)01541-N","volume":"35","author":"AF Monti","year":"1995","unstructured":"Monti AF, Ostinelli A, Frigerio M, Cosentino D, Bossi A, Cazzaniga LF, et al. An ICRU 50 radiotherapy treatment chart. Radiother Oncol. 1995;35:145\u201350.","journal-title":"Radiother Oncol"},{"key":"1720_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0167-8140(02)00140-8","volume":"64","author":"JC Stroom","year":"2002","unstructured":"Stroom JC. Geometrical uncertainties, radiotherapy planning margins, and the ICRU-62 report. Radiother Oncol. 2002;64:75\u201383.","journal-title":"Radiother Oncol"},{"key":"1720_CR13","unstructured":"Group RTO. A phase II study of intensity modulated radiation therapy (IMRT) +\/\u2212chemotherapy for nasopharyngeal cancer, RTOG 0225[2011-03-05]. http:\/\/208.251.169.72\/members\/protocols\/0225\/pdf_file.html."},{"key":"1720_CR14","unstructured":"Group RTO. A phase II study of concurrent chemoradiotherapy using three-dimensional conformal radiotherapy(3D-CRT) or inteusity-modulated radiation therapy (IMRT)+Bevaciztanab(BV) for locally or regionally advanced nasopharyngeal cancer, RTOG 0615[2011-03-05].\u00a0http:\/\/208.251.169.72\/members\/protocols\/0615\/0615.pdf."},{"key":"1720_CR15","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ijrobp.2018.10.006","volume":"103","author":"NN Sanford","year":"2019","unstructured":"Sanford NN, Lau J, Lam MB, Juliano AF, Adams JA, Goldberg SI, et al. Individualization of clinical target volume delineation based on stepwise spread of nasopharyngeal carcinoma: outcome of more than a decade of clinical experience. Int J Radiat Oncol Biol Phys. 2019;103:654\u201368.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1720_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.radonc.2015.02.017","volume":"115","author":"X Wang","year":"2015","unstructured":"Wang X, Hu C, Ying H, He X, Zhu G, Kong L, et al. Patterns of lymph node metastasis from nasopharyngeal carcinoma based on the 2013 updated consensus guidelines for neck node levels. Radiother Oncol. 2015;115:41\u20135.","journal-title":"Radiother Oncol"},{"key":"1720_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.radonc.2015.02.013","volume":"115","author":"J Zhang","year":"2015","unstructured":"Zhang J, Pan L, Ren J, Lang J, Wen H, Wang J, et al. Level IIb CTV delineation based on cervical fascia anatomy in nasopharyngeal cancer. Radiother Oncol. 2015;115:46\u20139.","journal-title":"Radiother Oncol"},{"key":"1720_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.radonc.2008.07.014","volume":"89","author":"X Wang","year":"2008","unstructured":"Wang X, Li L, Hu C, Zhou Z, Ying H, Ding J, et al. Patterns of level II node metastasis in nasopharyngeal carcinoma. Radiother Oncol. 2008;89:28\u201332.","journal-title":"Radiother Oncol"},{"key":"1720_CR19","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.canrad.2016.07.066","volume":"20","author":"Y Pointreau","year":"2016","unstructured":"Pointreau Y, Liz\u00e9e T, Bensadoun RJ, Boisselier P, Racadot S, Thariat J, et al. Intensity-modulated radiotherapy for head and neck cancer. Dose constraint for salivary gland and mandible. Cancer Radiother. 2016;20:445.","journal-title":"Cancer Radiother"},{"key":"1720_CR20","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ijrobp.2019.06.2540","volume":"105","author":"AW Lee","year":"2019","unstructured":"Lee AW, Ng WT, Pan JJ, Chiang C-L, Poh SS, Choi HC, et al. International guideline on dose prioritization and acceptance criteria in radiation therapy planning for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2019;105:567\u201380.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1720_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0360-3016(99)00247-3","volume":"45","author":"A Eisbruch","year":"1999","unstructured":"Eisbruch A, et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 1999;45:577\u201387.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1720_CR22","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0360-3016(00)01441-3","volume":"49","author":"KSC Chao","year":"2001","unstructured":"Chao KSC, Deasy JO, Markman J, Haynie J, Perez CA, Purdy JA, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys. 2001;49:907\u201316.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-020-01720-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-020-01720-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-020-01720-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T14:16:14Z","timestamp":1606140974000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-020-01720-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1720"],"URL":"https:\/\/doi.org\/10.1186\/s13014-020-01720-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-49951\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-49951\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-49951\/v3","asserted-by":"object"}]},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,23]]},"assertion":[{"value":"3 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional ethical committee (Ethics Committee of Jiangsu Institute of Cancer Research, the Affiliated Cancer Hospital of Nanjing Medical University).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets used and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data materials"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"270"}}